CLL 进展的临床试验
总计433015个结果
-
AstraZeneca主动,不招人第 1 部分:晚期 B 细胞恶性肿瘤 | 第 2 部分:r/rCLL 和 r/rMCL | 第 3 部分:未经治疗的 CLL日本
-
Weill Medical College of Cornell UniversityTG Therapeutics, Inc.终止
-
AvenCell Europe GmbHPHARMALOG Institut für klinische Forschung GmbH终止
-
Centre Leon BerardNational Cancer Institute, France; Fondation ARC完全的
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research Institute完全的临床孤立综合征 | 复发缓解型多发性硬化症 | 原发性进行性多发性硬化症 | 继发性进行性多发性硬化症美国
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.完全的
-
Assistance Publique Hopitaux De Marseille完全的
-
IRCCS San Raffaele招聘中
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.完全的
-
The First Affiliated Hospital of Xiamen University尚未招聘
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销
-
Opexa Therapeutics, Inc.完全的多发性硬化症 | 神经系统自身免疫性疾病 | 疾病进展 | 继发性进行性多发性硬化症 | 脑萎缩美国, 加拿大
-
Centre hospitalier de l'Université de Montréal...招聘中
-
Tianjin Medical University Cancer Institute and...尚未招聘无进展生存期(PFS)
-
University College Cork完全的
-
Fundació Institut de Recerca de l'Hospital de la...未知
-
Chang Gung Memorial Hospital完全的死亡 | 风险因素 | Renal Progression台湾
-
University of Colorado, DenverCancer League of Colorado完全的
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of Medicine未知
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer Center招聘中